EFFECT OF A HUMAN-IGG PREPARATION RICH IN ANTIBODIES TO A WIDE-RANGE OF LIPOPOLYSACCHARIDES ON GRAM-NEGATIVE BACTERIAL SEPSIS IN BURNED MICE

被引:14
作者
FOMSGAARD, A [1 ]
HOLDER, IA [1 ]
机构
[1] UNIV CINCINNATI,COLL MED,SHRINERS BURNS INST,CINCINNATI,OH 45221
关键词
LIPOPOLYSACCHARIDES; SEPTICEMIA; IMMUNOTHERAPY; BURNS;
D O I
10.1111/j.1699-0463.1993.tb00105.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A human intravenous IgG preparation (Anti-LPS IgG) rich in antibodies to different lipopolysaccharides (LPS) and a normal human intravenous IgG (NIgG) were investigated for their ability to confer passive immunity. Both preparations were given at the time of infection (prophylaxis) or during sepsis (therapy) to burned mice with lethal infection induced by various clinically relevant gram-negative bacteria. When given at the time of infection both IgG preparations (5 mg/mouse) inhibited lethality induced by some bacteria (Pseudomonas aeruginosa serogroup G and B), but not others (Serratia marcescens, Klebsiella pneumonia, Proteus mirabilis), indicating a protection by strain-specific antibodies. However, no significant protection was seen when mice were treated during sepsis. The range of specific antibody titers to the whole live bacteria and heat-killed (LPS-preserved) bacteria in the NIgG paralleled that of Anti-LPS IgG; however, the magnitude of the antibody titers did not accurately reflect the protective capacity in vivo. Thus, the exact specificity of the protective antibodies is still unknown. The protective effect of both IgG preparations was dose-dependent; at low IgG doses (0.5 mg/mouse) better protection was obtained with Anti-LPS IgG, whilst at higher doses (greater-than-or-equal-to 1 mg/mouse) both preparations exhibited identical effects. Low doses of either IgG preparation in combination with subtherapeutic doses of piperacillin significantly enhanced early survival (day 2 for NIgG and day 2 + 3 for Anti-LPS IgG) against P aeruginosa, but the protective effect waned thereafter. We conclude that a strain-specific antibacterial effect in a compromised mouse infection model can be obtained by early passive immunization with human IgG from large plasma pools. It is suggested that Anti-LPS IgG or NIgG may be of benefit in some cases of gram-negative sepsis when administered as prophylaxis together with proper antibiotic treatment.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 21 条
[1]  
APPELMELK BJ, 1987, ANTIBODIES LPS CORE, P13
[2]   BACTERIOSTATIC EFFECT OF SERUM - ROLE OF ANTIBODY TO LIPOPOLYSACCHARIDE [J].
FITZGERALD, SP ;
ROGERS, HJ .
INFECTION AND IMMUNITY, 1980, 27 (02) :302-308
[3]   IMMUNOCHEMICAL AND BIOLOGICAL REACTIVITY OF HUMAN ANTI-LIPOPOLYSACCHARIDE IGG OBTAINED BY SCREENING OF BLOOD-DONORS [J].
FOMSGAARD, A ;
ZHANG, GH ;
SHAND, GH ;
BENDTZEN, K ;
BAEK, L .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1989, 29 (03) :309-316
[4]   ELISA FOR HUMAN-IGG AND IGM ANTILIPOPOLYSACCHARIDE ANTIBODIES WITH INDIRECT STANDARDIZATION [J].
FOMSGAARD, A ;
DINESEN, B .
JOURNAL OF IMMUNOASSAY, 1987, 8 (04) :333-350
[5]   PRELIMINARY-STUDY ON TREATMENT OF SEPTIC SHOCK PATIENTS WITH ANTILIPOPOLYSACCHARIDE-IGG FROM BLOOD-DONORS [J].
FOMSGAARD, A ;
BAEK, L ;
FOMSGAARD, JS ;
ENGQUIST, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1989, 21 (06) :697-708
[6]   PROTECTIVE PROPERTIES OF A HUMAN-IGG PREPARATION RICH IN ANTIBODIES TO A WIDE SPECTRUM OF LIPOPOLYSACCHARIDES [J].
FOMSGAARD, A ;
GALANOS, C .
APMIS, 1989, 97 (12) :1114-1120
[7]  
FOMSGAARD A, 1990, APMIS S18, V98, P3
[8]  
Gaffin S L, 1985, Haematol Blood Transfus, V29, P107
[9]   A CONTROLLED CLINICAL-TRIAL OF E5 MURINE MONOCLONAL IGM ANTIBODY TO ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS [J].
GREENMAN, RL ;
SCHEIN, RMH ;
MARTIN, MA ;
WENZEL, RP ;
MACINTYRE, NR ;
EMMANUEL, G ;
CHMEL, H ;
KOHLER, RB ;
MCCARTHY, M ;
PLOUFFE, J ;
RUSSELL, JA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (08) :1097-1102
[10]  
HOLDER I, 1989, PSEUDOMONAS AERUGINO, V42, P109